Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: Results of a multicenter phase II study

2009 ◽  
Vol 114 (2) ◽  
pp. 288-292 ◽  
Author(s):  
D.S. McMeekin ◽  
A. Lisyanskaya ◽  
M. Crispens ◽  
A.M. Oza ◽  
P. Braly ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Single Agent ◽  
Second Line ◽  
Second Line Therapy ◽  
Multicenter Phase ◽  
Line Therapy ◽  
Recurrent Endometrial Cancer

A phase II study of single-agent nab-paclitaxel as second-line therapy in patients with metastatic urothelial carcinoma.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. TPS231-TPS231 ◽  
Author(s):  
S. S. Sridhar ◽  
C. M. Canil ◽  
S. D. Mukherjee ◽  
E. Winquist ◽  
C. Elser ◽  
...  
Keyword(s):  
Urothelial Carcinoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Single Agent ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Metastatic Urothelial Carcinoma

Phase II Study of Docetaxel and Gefitinib as Second-Line Therapy in Gemcitabine Pretreated Patients with Advanced Pancreatic Cancer

Oncology ◽  
2009 ◽  
Vol 76 (4) ◽  
pp. 270-274 ◽  
Author(s):  
Joanna M. Brell ◽  
Khalid Matin ◽  
Terry Evans ◽  
Robert L. Volkin ◽  
Gauri J. Kiefer ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Pancreatic Cancer ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Pretreated Patients

Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma

2009 ◽  
Vol 19 (3) ◽  
pp. 185-192 ◽  
Author(s):  
Tim Eisen ◽  
José Thomas ◽  
Wilson H. Miller ◽  
Martin Gore ◽  
Pascal Wolter ◽  
...  
Keyword(s):  
Malignant Melanoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Advanced Malignant Melanoma

scholarly journals Regorafenib as second line therapy for imatinib-resistant gastrointestinal stromal tumor (GIST): A phase II study

2019 ◽  
Vol 30 ◽  
pp. vi88
Author(s):  
Yoichi Naito ◽  
Toshihiko Doi ◽  
Tsuyoshi Takahashi ◽  
Toshihiro Kudo ◽  
Narikazu Boku ◽  
...  
Keyword(s):  
Gastrointestinal Stromal Tumor ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Stromal Tumor ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Imatinib Resistant
Sign in / Sign up

Export Citation Format

Share Document